language_icon
EN
HI

Anuh Pharma Share price

ANUHPHR

75.53

1.33 (-1.73%)
NSE
BSE
Last updated on 2 Jun, 2026 | 15:49 IST
Today's High

77.90

Today's Low

75.33

52 Week Low

67.00

52 Week High

114.90

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Anuh Pharma Chart

Anuh Pharma Share Key Metrics

Volume
38822.00
Market Cap
756.99 CR
LTQ@LTP
15@75.53
ATP
75.89
Var Margin
19 %
Circuit Range
61.49-92.23
Delivery %
70.96 %
Value
29.46 L
ASM/GSM
No
Market Lot
1

Summary

Anuh Pharma share price is ₹75.53 as of 3 Jun, 2026. The stock Anuh Pharma intraday movement has stayed between ₹75.33 and ₹77.90, while on a 52-week basis,Anuh Pharma price 52 week high is ₹114.90 & its 52 week low is ₹67.00.
In terms of trading activity, Anuh Pharma has recorded a volume of 38822 shares, The Anuh Pharma has a market cap of ₹100224000 CR. The stock’s Average Traded Price (ATP) stands at ₹75.89, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 15 @ ₹75.53.
Anuh Pharma operates within a circuit range of ₹61.49 – ₹92.23, with a Value of ₹29.46 L. The Delivery Percentage for the day is 70.96%. Additionally, Anuh Pharma currently falls under the No framework, and trades with a market lot size of 1.

Anuh Pharma Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

69.94

Sector P/B

2.97

Sec. Div. Yield

0.55

Anuh Pharma Resistance and Support

Pivot 76.65

Resistance

First Resistance

78.3

Second Resistance

79.75

Third Resistance

81.4

Support

First Support

75.2

Second Support

73.55

Third Support

72.1

Anuh Pharma Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

71.8%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.05%

Domestic Institutional Investors

0%

Retail

28.16%

Others

-0.01%

Total Promoters
MAR '26
71.8%

Anuh Pharma Corporate Actions

DateAgenda
2026-05-20Audited Results
2026-02-06Quarterly Results
2025-11-07Quarterly Results
2025-08-08Quarterly Results & Others
2025-05-23Audited Results
2025-02-07Quarterly Results & Others

Anuh Pharma News

Anuh Pharma Ltd - 506260 - Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Anuh Pharma applied to stock exchanges for reclassification of certain persons from the Promoter Group to the Public category. This involves 0.95% of total shares.
May 25 2026 23:28:39

Anuh Pharma Ltd - 506260 - Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Anuh Pharma's Board approved the re-classification of 0.94% of its promoter group shareholding to the public category. This move aligns with SEBI Regulation 31A, as the shareholders are not involved in the company's management or operations.
May 22 2026 19:09:54

Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - Adoption For Policy For Implementation Of NFRA Circular

Anuh Pharma's Board approved the re-classification of specific promoter group shareholders, representing 0.95% of total shareholding, to the public category. This change is subject to approval from the company's shareholders at the upcoming AGM.
May 20 2026 23:55:04

Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - Appointment Of Scrutinizer For The 66Th Annual General Meeting.

Anuh Pharma's Board approved the re-classification of specific promoter group shareholders, representing 0.95% of total shareholding, to the public category. This change is subject to approval from the company's shareholders at the upcoming AGM.
May 20 2026 23:51:08

Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - 66Th Annual General Meeting Will Be Held On Wednesday, 12Th August, 2026.

Anuh Pharma's Board approved the re-classification of specific promoter group shareholders, representing 0.95% of total shareholding, to the public category. This change is subject to approval from the company's shareholders at the upcoming AGM.
May 20 2026 23:47:21

Anuh Pharma Ltd - 506260 - Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Anuh Pharma's Board approved the re-classification of specific promoter group shareholders, representing 0.95% of total shareholding, to the public category. This change is subject to approval from the company's shareholders at the upcoming AGM.
May 20 2026 23:38:01

Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - Granting Authorization To Key Managerial Personnel For Determination Of Materiality Of Events.

Anuh Pharma's board approved the audited financial results for FY26 and recommended a final dividend. Additionally, the board adopted new Memorandum and Articles of Association and reclassified 0.95% of shares from the promoter to the public category.
May 20 2026 23:29:52

Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - Adoption Of Memorandum Of Association (MOA) And Articles Of Association (AOA) As Per Companies Act, 2013

Anuh Pharma's Board approved audited financial results for FY26 and recommended a final dividend of Rs. 1.50 per equity share. The record date for the dividend is August 5, 2026, and the AGM will be held on August 12, 2026.
May 20 2026 23:25:01

Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - Appointment Of Internal Auditor.

Anuh Pharma's board approved audited financial results for FY26, reporting Rs. 771.66 cr revenue (up 16.65% YoY) and Rs. 41.05 cr PAT (down 13.31% YoY). A final dividend of Rs. 1.50 per equity share was recommended, with August 5, 2026, as the record date.
May 20 2026 23:04:52

Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - Appointment Of Mr. P.N. Rao As General Manager - Quality

Anuh Pharma's Board approved audited financial results for FY26 and recommended a final dividend of Rs. 1.50 per equity share. The record date for the dividend is August 5, 2026, and the AGM will be held on August 12, 2026.
May 20 2026 23:02:30
Read More

Anuh Pharma Management

NamePosition
Manan Jayesh VadhanCompany Secretary & Compliance Officer
Arun TodarwalChairman
View More

Anuh Pharma FAQs

The Buying Price of Anuh Pharma share is 75.53 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Anuh Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Anuh Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Anuh Pharma shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Anuh Pharma shares is 0. Useful to assess the stock's value relative to its book value.

To assess Anuh Pharma’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.

The Market Cap of Anuh Pharma is 756.99 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Anuh Pharma share price is 114.90 & 67.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Anuh Pharma belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost